RG
BVS icon

Redmile Group’s Bioventus BVS Stock Holding History

Redmile Group’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-535,950
Closed -$1.4M – 77
2022
Q4 		$1.4M Sell
535,950
-763,189
-59% -$3.33M 0.06% 64
2022
Q3 		$9.09M Sell
1,299,139
-7,200
-0.6% -$56.4K 0.35% 51
2022
Q2 		$8.91M Buy
1,306,339
+9,600
+0.7% +$98K 0.34% 51
2022
Q1 		$18.3M Sell
1,296,739
-28,400
-2% -$380K 0.57% 43
2021
Q4 		$19.2M Sell
1,325,139
-164,717
-11% -$2.34M 0.44% 47
2021
Q3 		$21.1M Buy
1,489,856
+2,900
+0.2% +$44.6K 0.37% 53
2021
Q2 		$26.2M Sell
1,486,956
-13,044
-0.9% -$210K 0.39% 58
2021
Q1 		$22.9M Buy
+1,500,000
New +$21.4M 0.32% 64

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Redmile Group's BVS Position: Q1 2023 in Review

Redmile Group sold out of Bioventus (BVS) in Q1 2023, closing a stake of 535,950 shares — an estimated $1.4M sold.

Redmile Group first reported a position in BVS in Q1 2021 and held it in 8 quarters. The position peaked at $26.2M in Q2 2021. 71 funds tracked by Wall St. Rank hold BVS as of Q1 2023.

  • Redmile Group reported no remaining Bioventus position as of Q1 2023 after selling out during the quarter.
  • Redmile Group sold 535,950 Bioventus shares in Q1 2023, an estimated $1.4M.
  • Redmile Group first reported a position in Bioventus in Q1 2021 and held it in 8 quarters.
  • Redmile Group's Bioventus position peaked at $26.2M in Q2 2021.
  • 71 funds tracked by Wall St. Rank held Bioventus as of Q1 2023.

Based on Redmile Group's 13F filing for Q1 2023, filed 15 May 2023.